Ogast



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 67.2%
Ill-defined Disorder 14.9%
Cardiac Failure 6.0%
Neuralgia 4.5%
Chronic Obstructive Pulmonary Disease 3.0%
Gastrooesophageal Reflux Disease 3.0%
Hypertension 1.5%
Hypersensitivity Vasculitis 16.7%
Leukocytoclastic Vasculitis 16.7%
Lung Disorder 16.7%
Renal Failure Acute 16.7%
Hypogammaglobulinaemia 8.3%
Lung Infection 8.3%
Rash Generalised 8.3%
Reading Disorder 8.3%
Secondary
Drug Use For Unknown Indication 39.7%
Product Used For Unknown Indication 24.0%
Hypertension 6.0%
Diabetes Mellitus 3.7%
Bronchitis 3.0%
Osteitis 3.0%
Anxiety 2.6%
Back Pain 2.2%
Rheumatoid Arthritis 2.2%
Gastritis 1.9%
Depression 1.5%
Hyperlipidaemia 1.5%
Prostate Cancer 1.5%
Arrhythmia 1.1%
Atrial Fibrillation 1.1%
Gastric Ulcer 1.1%
Prophylaxis 1.1%
Thrombosis Prophylaxis 1.1%
Alcoholism 0.7%
Angina Pectoris 0.7%
Thrombocytopenia 18.0%
Toxic Skin Eruption 10.0%
Lung Disorder 8.0%
Pruritus 8.0%
Hypogammaglobulinaemia 6.0%
Weight Decreased 6.0%
Interstitial Lung Disease 4.0%
Prothrombin Level Decreased 4.0%
Pruritus Generalised 4.0%
Pulmonary Fibrosis 4.0%
Rash Maculo-papular 4.0%
Tuberculosis 4.0%
Vascular Purpura 4.0%
White Blood Cell Count Increased 4.0%
Eosinophilic Fasciitis 2.0%
Gout 2.0%
Haemolytic Anaemia 2.0%
Hypersensitivity Vasculitis 2.0%
Hypotonia 2.0%
Jaundice Cholestatic 2.0%
Concomitant
Drug Use For Unknown Indication 21.8%
Product Used For Unknown Indication 19.0%
Rheumatoid Arthritis 7.4%
Unevaluable Event 5.6%
Ill-defined Disorder 5.1%
Hypertension 4.7%
Hepatitis C 4.0%
Psoriatic Arthropathy 3.8%
Prophylaxis 3.5%
Depression 3.0%
Lung Infection 3.0%
Pain 3.0%
Neuralgia 2.7%
Hiv Infection 2.4%
Insomnia 2.4%
Pyelonephritis Acute 2.2%
Atrial Fibrillation 2.0%
Cardiac Failure 1.7%
Lung Neoplasm Malignant 1.5%
Back Pain 1.3%
Vomiting 10.0%
Renal Failure Acute 9.1%
Stevens-johnson Syndrome 9.1%
Somnolence 7.3%
Malaise 5.5%
Renal Failure 5.5%
Pain In Extremity 4.5%
Pulmonary Fibrosis 4.5%
Respiratory Distress 4.5%
Weight Decreased 4.5%
Cholestasis 3.6%
Gamma-glutamyltransferase Increased 3.6%
Hyponatraemia 3.6%
Jaundice 3.6%
Renal Failure Chronic 3.6%
Renal Neoplasm 3.6%
Thrombocytopenia 3.6%
Transaminases Increased 3.6%
Urinary Tract Infection 3.6%
Carbon Monoxide Diffusing Capacity Decreased 2.7%
Interacting
Tachyarrhythmia 100.0%
Hypogammaglobulinaemia 25.0%
International Normalised Ratio Increased 25.0%
Lung Disorder 25.0%
Pneumonia 25.0%